表紙
市場調查報告書

體外受精 (IVF)的世界市場規模·佔有率·趨勢分析:各類型·設備 (拋棄式用品,培養基,資本設備)·各最終用途·各地區·各領域的未來預測

In-Vitro Fertilization Market Size, Share & Trends Analysis Report By Instrument (Disposable Devices, Culture Media, Capital Equipment), By Procedure Type, By End Use, By Region, And Segment Forecasts, 2020 - 2027

出版商 Grand View Research, Inc. 商品編碼 358138
出版日期 內容資訊 英文 120 Pages
商品交期: 2-3個工作天內
價格
體外受精 (IVF)的世界市場規模·佔有率·趨勢分析:各類型·設備 (拋棄式用品,培養基,資本設備)·各最終用途·各地區·各領域的未來預測 In-Vitro Fertilization Market Size, Share & Trends Analysis Report By Instrument (Disposable Devices, Culture Media, Capital Equipment), By Procedure Type, By End Use, By Region, And Segment Forecasts, 2020 - 2027
出版日期: 2020年02月21日內容資訊: 英文 120 Pages
簡介

本報告提供全球體外受精 (IVF)的市場相關分析,提供技術概要和市場基本結構,主要的推動及阻礙市場要素,整體市場趨勢預測 (過去4年·今後8年份),設備·各類型·各最終用途·各地區的詳細趨勢,市場競爭形勢,主要企業簡介等調查。

第1章 調查手法和範圍

第2章 摘要整理

第3章 變動要素·趨勢·範圍

  • 相關市場未來展望
    • 母體市場分析
    • 相關/附隨物市場分析
  • 市場區隔
  • 產品普及率·市場成長率預測:製圖
  • 臨床實驗趨勢
  • 用戶方面的見解分析
    • 消費行為分析
    • 市場影響要素 (影響者)
  • 管理體制與醫療費償付方案:各地區
  • 市場動態
    • 推動市場要素
    • 阻礙市場要素
    • 波特的五力分析
  • 商務環境分析工具
    • SWOT分析:要因別 (政治·法律·經濟·技術性要素)
    • 主要的資本交易/策略性聯合趨勢分析
      • 合資企業
      • 企業合併·收購 (M&A)
  • 體外受精 (IVF) 循環的數量

第4章 體外受精 (IVF) 市場:設備分別分析

  • 市場佔有率分析:設備 (最新值·預測值)
  • 設備一覽
  • 市場規模:設備 (今後9年份)
  • 市場規模·預測,趨勢分析:設備 (以金額為準,總計12年份)
    • 培養基
    • 拋棄式用品
    • 資本設備

第5章 體外受精 (IVF) 市場:不同種類的分析

  • 市場佔有率分析:設備 (最新值·預測值)
  • 種類一覽
  • 市場規模:各類型 (今後9年份)
  • 市場規模·預測,趨勢分析:各類型 (以金額為準,總計12年份)
    • 新鮮捐贈者
    • 凍結捐贈者
    • 非新鮮捐贈者
    • 非凍結捐贈者

第6章 體外受精 (IVF) 市場:各最終用途分析

  • 市場佔有率分析:設備 (最新值·預測值)
  • 最終用途一覽
  • 市場規模:設備 (今後9年份)
  • 市場規模·預測,趨勢分析:各最終用途 (以金額為準,總計12年份)
    • 肥胖症診所
    • 醫院等

第7章 各地區的未來展望

  • 定義和範圍
  • 市場佔有率分析 (最新值·預測值)
  • 地區一覽
  • 各地區的市場概要 (市場規模,年複合成長率 (CAGR),主要的需求處,主要企業,主要趨勢)
  • SWOT分析:各地區·要因別 (政治·法律·經濟·技術性要素)
  • 市場規模與其預測,趨勢分析 (以金額為準,今後9年份)
    • 北美市場 (美國,加拿大)
    • 歐洲市場 (英國,德國,法國,義大利,西班牙,荷蘭,瑞士,比利時)
    • 亞太地區 (日本,中國,印度)
    • 南美 (巴西,墨西哥)
    • 中東·非洲 (南非)

第8章 競爭環境

  • 策略性架構/企業的分類 (主要創新者,市場領導,新興企業)
  • 供應商環境
    • 策略製圖
    • 新產品的銷售
    • 企業合併·收購 (M&A)
    • 對其他地區的進出
    • 事業聯盟
  • 公共企業
    • 市場地位分析 (市場收益額,各地區的存在感,產品系列,主要的需求處產業,主要企業聯盟)
  • 民營企業
    • 新企業/技術一覽
    • 市場地位分析 (各地區的存在感,產品系列,主要的需求處產業,產業的經驗)
  • 企業簡介
    • OVASCIENCE, INC.
      • 企業概要
      • 財務實際成果
      • 產品的互相比較
      • 策略部署情形
      • SWOT分析
    • VITROLIFE
    • EMD SERONO, INC.
    • IRVINE SCIENTIFIC
    • THE COOPER COMPANIES, INC.
    • COOK MEDICAL (COOK GROUP)
    • THERMO FISHER SCIENTIFIC, INC.
    • GENEA BIOMEDX
    • PROGYNY, INC.
    • BOSTON IVF
    • ORIGIO
    • FERRING PHARMACEUTICAL
    • BAYER AG
    • MERCK & CO., INC.
    • ORGANON

第9章 KOL (產業意見領袖)的意見與建議

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: 978-1-68038-823-7

The global in-vitro fertilization market size is expected to reach USD 37.7 billion by 2027, expanding at a CAGR of 9.5%, based on a new report by Grand View Research, Inc. The market is driven by increasing incidence of infertility owing to lifestyle changes, government initiatives to provide better reimbursement policies, and the continuous efforts by the industry contributors. Expansion of fertility procedures for treating male infertility, such as ICSI, is projected to positively influence the growth in near future.

Moreover, the availability of genomic testing enabling the prevention of the transfer of genetic disease during in-vitro fertilization (IVF) use is further expected to drive the IVF market. The increase in the number of IVF treatment has led more insurance players to cover the procedures. This has ultimately led to competitive pricing and has moderated the IVF treatment costs as the procedure has been a successfully practiced technology, which has driven the market with more treatment standardization and automation.

The behavioral shift in the society is the major factor contributing to the decreased Total Fertility Rate (TFR). These factors include an increasing number of women in the labor force, the increased age of the first birth, a shift from rural to urban societies, lower marriage rates, and postponement of marriage.

Obesity is another factor leading to an increase in infertility. The fat deposited on women's abdomen prevents follicular stimulation and produces male hormones. In case of males, rising fat deposits decrease testosterone levels and can result in lowered sperm production. Doctors recommend weight loss in men prior to fertility treatments along with proper maintenance of Body Mass Index (BMI). The U.S. Endocrine Society has established the use of Letrozole to increase the testosterone levels in obese patients.

Further key findings from the study suggest:

  • Culture media dominated the overall in-vitro fertilization market in terms of revenue in 2019. With the increasing government funding and industrial support for employees for egg/sperm freezing, the demand for cryopreservation and the required media for it, is expected to witness growth
  • Moreover, the increasing number of egg/sperm donor banks is expected to drive the demand for sperm, egg, and embryo processing media during the forecast period
  • The fresh non-donor segment dominated the IVF market in 2019. According to the 2003 - 2012 trends by the CDC, the number of fresh non-donors banking the eggs/embryos for future use has drastically increased in U.S.
  • Europe dominated the procedure and instrument market for in-vitro fertilization in 2019. High quality of treatment offered at the most economical price, and the adherence to medical standards have contributed to its market leadership
  • In Europe, the NHS covers three IVF cycles and has also started providing coverage for gametes freezing. Moreover, the region is an attraction for international clients as countries, such as Spain, have the highest number of egg donors. The clinics also provide sex identification and other IVF treatments, which are not offered in North America
  • North America also accounted for a significant share of the market in 2019. The standardization of procedures through automation, regulatory reforms, government funding for egg/sperm storage, and industry players introducing more IVF treatments are some contributing factors for market growth in the region
  • The presence of favorable reimbursement framework (implementation of USD 50 million 5-year plans by the U.S Department of Defense for sperm/egg freezing coverage) is also expected to drive regional market growth over the next six years. The increasing number of clinics undertaking newer techniques to offer better fertility success rates is also expected to increase the demand in the region
  • The demand for IVF treatment is expected to boom in APAC owing to fertility tourism and increasing penetration and awareness of the treatment in the developing economies of the region
  • The Asia Pacific Initiative on Reproduction (ASPIRE), the task force of clinicians and scientists is involved in the monitoring and management of fertility and Assisted Reproductive Technology (ART). Such initiatives promote awareness levels thereby, driving the market
  • Industry contributors are introducing newer automation to shift the IVF treatment from invasive to a minimally invasive or non-invasive procedure. The industry players are also working on technologies, which can enable older women to have enhanced fertility rates
  • Some of the key players in the market include EMD Serono Inc.; Boston IVF; OvaScience; Thermo Fisher Scientific Inc.; Vitrolife AB; Irvine Scientific; CooperSurgical, Inc.; Cook Medical Inc.; Genea Biomedx and Progyny Inc.
  • In October 2018, Vitrolife entered into a licensing and commercialization agreement with Illumina, Inc. This will provide Vitrolife with exclusive distribution, development, and commercialization rights to Illumina's preimplantation genetic testing business in Europe, Middle East and Africa, and North America.

Table of Contents

Chapter 1 Research Objectives

  • 1.1 Objective - 1:
  • 1.2 Objective - 2:

Chapter 2 Executive Summary

  • 2.1 Market Outlook
  • 2.2 Segment Outlook
  • 2.3 Competitive Insights

Chapter 3 Market Variables, Trends & Scope

  • 3.1 Market Lineage Outlook
    • 3.1.1 Parent Market Outlook
    • 3.1.2 Related/Ancillary Market Outlook
  • 3.2 Market Segmentation
  • 3.3 Penetration & Growth Prospect Mapping
  • 3.4 Clinical Trials
  • 3.5 User Perspective Analysis
    • 3.5.1 Consumer Behavior Analysis
    • 3.5.2 Market Influencer Analysis
  • 3.6 Regulatory Framework & Reimbursement Scenario
    • 3.6.1 North America
    • 3.6.2 Europe
    • 3.6.3 Asia Pacific
    • 3.6.4 Latin America
    • 3.6.5 Middle East & Africa
  • 3.7 Market Dynamics
    • 3.7.1 Market Driver Analysis
      • 3.7.1.1 Rising reprotourism
      • 3.7.1.2 Technological advancements in IVF
      • 3.7.1.3 Favorable government funding
      • 3.7.1.4 Late initiation of family
      • 3.7.1.5 Increasing incidence rate of male and female infertility
      • 3.7.1.6 Mergers and acquisitions (M&A)
    • 3.7.2 Market Restraint Analysis
      • 3.7.2.1 High cost of IVF treatment
      • 3.7.2.2 Lack of regulatory framework and uniform regulations
    • 3.7.3 Porter's Five Forces Analysis
      • 3.7.3.1 Bargaining power of buyers
      • 3.7.3.2 Bargaining power of suppliers
      • 3.7.3.3 Competitive rivalry
      • 3.7.3.4 Threat of new entrants
      • 3.7.3.5 Threat of substitutes
  • 3.8 Business Environment Analysis Tools
    • 3.8.1 Swot Analysis, By Pestel
      • 3.8.1.1 Political & legal
      • 3.8.1.2 Economic
      • 3.8.1.3 Technological
    • 3.8.2 Major Deals & Strategic Alliances Analysis
      • 3.8.2.1 Joint ventures
      • 3.8.2.2 Mergers & acquisitions

Chapter 4 In-Vitro Fertilization (IVF) Market: Instrument Analysis

  • 4.1 In-Vitro Fertilization (IVF) Market Share Analysis, 2019 & 2027
  • 4.2 Segment Dashboard
  • 4.3 In-Vitro Fertilization (IVF) Market, by Instrument, 2016 to 2027
  • 4.4 Market Size & Forecasts and Trend Analysis, 2016 to 2027 for the Instrument
    • 4.4.1 Culture Media
      • 4.4.1.1 Culture media market, 2016 - 2027 (USD Million)
    • 4.4.2 Disposable Devices
      • 4.4.2.1 Disposable devices market, 2016 - 2027 (USD Million)
    • 4.4.3 Capital Equipment
      • 4.4.3.1 Capital equipment market, 2016 - 2027 (USD Million)

Chapter 5 In-Vitro Fertilization (IVF) Market: Procedure Type Analysis

  • 5.1 In-Vitro Fertilization (IVF) by Type Market Share Analysis, 2019 & 2027
  • 5.2 Segment Dashboard
  • 5.3 Global IVF Market, by Treatment Type, 2016 - 2027
  • 5.4 Market Size & Forecasts and Trend Analysis, 2015 to 2026 for the Treatment Type
    • 5.4.1 Fresh Nondonor
      • 5.4.1.1 Fresh nondonor market, 2016 - 2027 (USD Million)
    • 5.4.2 Frozen Nondonor
      • 5.4.2.1 Frozen nondonor market, 2016 - 2027 (USD Million)
    • 5.4.3 Fresh Donor
      • 5.4.3.1 Fresh donor market, 2016 - 2027 (USD Million)
    • 5.4.4 Frozen Donor
      • 5.4.4.1 Frozen donor market, 2016 - 2027 (USD Million)

Chapter 6 In-Vitro Fertilization (IVF) Market: End-use Analysis

  • 6.1 In-Vitro Fertilization (IVF) End-use Market Share Analysis, 2019 & 2027
  • 6.2 Segment Dashboard
  • 6.3 In-Vitro Fertilization (IVF) Market, by End Use, 2016 - 2027
  • 6.4 Market Size & Forecasts and Trend Analysis, 2016 to 2027 for the Following End Use
    • 6.4.1 Fertility Clinics
      • 6.4.1.1 Fertility clinics market, 2016 - 2027 (USD Million)
    • 6.4.2 Hospitals & Other Settings
      • 6.4.2.1 Hospitals & other settings market, 2016 - 2027 (USD Million)

Chapter 7 Regional Outlook

  • 7.1 Definitions & Scope
  • 7.2 Regional Market Share Analysis, 2019 & 2027
  • 7.3 Regional Market Dashboard
  • 7.4 Regional Market Snapshot (Market Size, CAGR, Top Verticals, Key Players, Top Trends)
  • 7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
    • 7.5.1 North America
    • 7.5.2 Europe
    • 7.5.3 Asia Pacific
    • 7.5.4 Latin America
    • 7.5.5 MEA
  • 7.6 Market Size, & Forecasts and Trend Analysis, 2019 to 2027
    • 7.6.1 North America
      • 7.6.1.1 North America in-vitro fertilization market, 2016 - 2027 (USD Million)
      • 7.6.1.2 U.S.
      • 7.6.1.2.1 U.S. in-vitro fertilization market, 2016 - 2027 (USD Million)
      • 7.6.1.3 Canada
      • 7.6.1.3.1 Canada in-vitro fertilization market, 2016 - 2027 (USD Million)
    • 7.6.2 Europe
      • 7.6.2.1 Europe in-vitro fertilization market, 2016 - 2027 (USD Million)
      • 7.6.2.2 U.K.
      • 7.6.2.2.1 U.K. in-vitro fertilization market, 2016 - 2027 (USD Million)
      • 7.6.2.3 Germany
      • 7.6.2.3.1 Germany in-vitro fertilization market, 2016 - 2027 (USD Million)
      • 7.6.2.4 France
      • 7.6.2.4.1 France in-vitro fertilization market, 2016 - 2027 (USD Million)
      • 7.6.2.5 Italy
      • 7.6.2.5.1 Italy in-vitro fertilization market, 2016 - 2027 (USD Million)
      • 7.6.2.6 Spain
      • 7.6.2.6.1 Spain in-vitro fertilization market, 2016 - 2027 (USD Million)
      • 7.6.2.7 Netherlands
      • 7.6.2.7.1 Netherlands in-vitro fertilization market, 2016 - 2027 (USD Million)
      • 7.6.2.8 Switzerland
      • 7.6.2.8.1 Switzerland in-vitro fertilization market, 2016 - 2027 (USD Million)
      • 7.6.2.9 Belgium
      • 7.6.2.9.1 Belgium in-vitro fertilization market, 2016 - 2027 (USD Million)
    • 7.6.3 Asia Pacific
      • 7.6.3.1 Asia Pacific in-vitro fertilization market, 2016 - 2027 (USD Million)
      • 7.6.3.2 Japan
      • 7.6.3.2.1 Japan in-vitro fertilization market, 2016 - 2027 (USD Million)
      • 7.6.3.3 China
      • 7.6.3.3.1 China in-vitro fertilization market, 2016 - 2027 (USD Million)
      • 7.6.3.4 India
      • 7.6.3.4.1 India in-vitro fertilization market, 2016 - 2027 (USD Million)
    • 7.6.4 Latin America
      • 7.6.4.1 Latin America in-vitro fertilization market, 2016 - 2027 (USD Million)
      • 7.6.4.2 Brazil
      • 7.6.4.2.1 Brazil in-vitro fertilization market, 2016 - 2027 (USD Million)
      • 7.6.4.3 Mexico
      • 7.6.4.3.1 Mexico in-vitro fertilization market, 2016 - 2027 (USD Million)
    • 7.6.5 Middle East And Africa
      • 7.6.5.1 MEA in-vitro fertilization market, 2016 - 2027 (USD Million)
      • 7.6.5.2 South Africa
      • 7.6.5.2.1 South Africa in-vitro fertilization market, 2016 - 2027 (USD Million)

Chapter 8 Competitive Analysis

  • 8.1 Strategic Framework/ Competition Categorization (Key innovators, Market leaders, emerging players
  • 8.2 Vendor Landscape
    • 8.2.1 Strategy Mapping
    • 8.2.2 Launch Of New Products:
    • 8.2.3 Merger And Acquisition:
    • 8.2.4 Geographical Expansion:
    • 8.2.5 Partnerships:
  • 8.3 Public Companies
    • 8.3.1 Company Market Position Analysis (Revenue, Geographic Presence, Product Portfolio, Key Serviceable Industries, Key Alliances)
  • 8.4 Private Companies
    • 8.4.1 List Of Key Emerging Companies/Technology
    • 8.4.2 Company Market Position Analysis (Geographic Presence, Product Portfolio, Key Alliance, Industry Experience)
  • 8.5 Company Profiles
    • 8.5.1 OVASCIENCE, INC.
      • 8.5.1.1 Company overview
      • 8.5.1.2 Financial performance
      • 8.5.1.3 Product benchmarking
      • 8.5.1.4 Strategic initiatives
      • 8.5.1.5 SWOT analysis
    • 8.5.2 VITROLIFE
      • 8.5.2.1 Company overview
      • 8.5.2.2 Financial performance
      • 8.5.2.3 Product benchmarking
      • 8.5.2.4 Strategic initiatives
      • 8.5.2.5 SWOT analysis
    • 8.5.3 EMD SERONO, INC.
      • 8.5.3.1 Company overview
      • 8.5.3.2 Financial performance
      • 8.5.3.3 Product benchmarking
      • 8.5.3.4 Strategic initiatives
      • 8.5.3.5 SWOT analysis
    • 8.5.4 IRVINE SCIENTIFIC
      • 8.5.4.1 Company overview
      • 8.5.4.2 Financial performance
      • 8.5.4.3 Product benchmarking
      • 8.5.4.4 Strategic initiatives
      • 8.5.4.5 SWOT analysis
    • 8.5.5 THE COOPER COMPANIES, INC.
      • 8.5.5.1 Company overview
      • 8.5.5.2 Product benchmarking
      • 8.5.5.3 SWOT analysis
    • 8.5.6 COOK MEDICAL (COOK GROUP)
      • 8.5.6.1 Company overview
      • 8.5.6.2 Product benchmarking
      • 8.5.6.3 Strategic initiatives
      • 8.5.6.4 SWOT analysis
    • 8.5.7 THERMO FISHER SCIENTIFIC, INC.
      • 8.5.7.1 Company overview
      • 8.5.7.2 Financial performance
      • 8.5.7.3 Product benchmarking
      • 8.5.7.4 Strategic initiatives
      • 8.5.7.5 SWOT analysis
    • 8.5.8 GENEA BIOMEDX
      • 8.5.8.1 Company overview
      • 8.5.8.2 Product benchmarking
      • 8.5.8.3 Strategic initiatives
      • 8.5.8.4 SWOT analysis
    • 8.5.9 PROGYNY, INC.
      • 8.5.9.1 Company overview
      • 8.5.9.2 Financial performance
      • 8.5.9.3 Product benchmarking
      • 8.5.9.4 Strategic initiatives
      • 8.5.9.5 SWOT analysis
    • 8.5.10 BOSTON IVF
      • 8.5.10.1 Company overview
      • 8.5.10.2 Financial performance
      • 8.5.10.3 Product benchmarking
      • 8.5.10.4 Strategic initiatives
      • 8.5.10.5 SWOT analysis
    • 8.5.11 ORIGIO
      • 8.5.11.1 Company overview
      • 8.5.11.2 Financial performance
      • 8.5.11.3 Product benchmarking
      • 8.5.11.4 Strategic initiatives
      • 8.5.11.5 SWOT analysis
    • 8.5.12 FERRING PHARMACEUTICAL
      • 8.5.12.1 Company overview
      • 8.5.12.2 Financial performance
      • 8.5.12.3 Product benchmarking
      • 8.5.12.4 Strategic initiatives
      • 8.5.12.5 SWOT analysis
    • 8.5.13 BAYER AG
      • 8.5.13.1 Company overview
      • 8.5.13.2 Financial performance
      • 8.5.13.3 Product benchmarking
      • 8.5.13.4 Strategic initiatives
      • 8.5.13.5 SWOT analysis
    • 8.5.14 MERCK & CO., INC.
      • 8.5.14.1 Company overview
      • 8.5.14.2 Financial performance
      • 8.5.14.3 Product benchmarking
      • 8.5.14.4 Strategic initiatives
      • 8.5.14.5 SWOT analysis
    • 8.5.15 ORGANON
      • 8.5.15.1 Company overview
      • 8.5.15.2 Financial performance
      • 8.5.15.3 Product benchmarking
      • 8.5.15.4 Strategic initiatives
      • 8.5.15.5 SWOT analysis

Chapter 9 KOL Commentary & Recommendations

Chapter 10 Research Methodology & Scope

  • 10.1 Research Methodology
    • 10.1.1 Information procurement
      • 10.1.1.1 Purchased database:
      • 10.1.1.2 GVR's internal database
    • 10.1.2 Primary research:
  • 10.2 Research Scope and Assumptions
  • 10.3 List to Data Sources

Chapter 11 Report FAQs

  • 11.1 How Do I Trust Your Report Quality/Data Accuracy?
  • 11.2 My Research Requirement Is Very Specific; Can I Customize This Report?
  • 11.3 I have a pre-defined budget. Can I buy chapters/sections of this report?
  • 11.4 How Do You Arrive At These Market Numbers?
  • 11.5 Who Are Your Clients?
  • 11.6 How Will I Receive This Report?

Chapter 12 Appendix

Chapter 13 Compass - Cloud Based Report Delivery Platform

Chapter 14 Related Reports

List of Tables

  • TABLE 1 List of secondary sources
  • TABLE 2 List of Abbreviation
  • TABLE 3 Clinical trial analysis
  • TABLE 4 Cost variations for IVF treatment throughout different countries
  • TABLE 5 Comparison between fresh and frozen donor treatment (USA)
  • TABLE 6 North America IVF Market, by Country, 2016 - 2027 (USD Million)
  • TABLE 7 North America IVF Market, by Instrument, 2016 - 2027 (USD Million)
  • TABLE 8 North America IVF Market, by procedure type, 2016 - 2027 (USD Million)
  • TABLE 9 North America IVF Market, by End Use, 2016 - 2027 (USD Million)
  • TABLE 10 U.S. IVF Market, by Instrument, 2016 - 2027 (USD Million)
  • TABLE 11 U.S. IVF Market, by procedure type, 2016 - 2027 (USD Million)
  • TABLE 12 U.S. IVF Market, by End Use, 2016 - 2027 (USD Million)
  • TABLE 13 Current Canadian Law on ART
  • TABLE 14 Canada IVF Market, by Instrument, 2016 - 2027 (USD Million)
  • TABLE 15 Canada IVF Market, by procedure type, 2016 - 2027 (USD Million)
  • TABLE 16 Canada IVF Market, by End Use, 2016 - 2027 (USD Million)
  • TABLE 17 Europe IVF Market, by Country, 2016 - 2027 (USD Million)
  • TABLE 18 Europe IVF Market, by Instrument, 2016 - 2027 (USD Million)
  • TABLE 19 Europe IVF Market, by procedure type, 2016 - 2027 (USD Million)
  • TABLE 20 Europe IVF Market, by End Use, 2016 - 2027 (USD Million)
  • TABLE 21 U.K. IVF Market, by Instrument, 2016 - 2027 (USD Million)
  • TABLE 22 U.K. IVF Market, by procedure type, 2016 - 2027 (USD Million)
  • TABLE 23 U.K. IVF Market, by End Use, 2016 - 2027 (USD Million)
  • TABLE 24 Germany IVF Market, by Instrument, 2016 - 2027 (USD Million)
  • TABLE 25 Germany IVF Market, by procedure type, 2016 - 2027 (USD Million)
  • TABLE 26 Germany IVF Market, by End Use, 2016 - 2027 (USD Million)
  • TABLE 27 France IVF Market, by Instrument, 2016 - 2027 (USD Million)
  • TABLE 28 France IVF Market, by procedure type, 2016 - 2027 (USD Million)
  • TABLE 29 France IVF Market, by End Use, 2016 - 2027 (USD Million)
  • TABLE 30 Italy IVF Market, by Instrument, 2016 - 2027 (USD Million)
  • TABLE 31 Italy IVF Market, by procedure type, 2016 - 2027 (USD Million)
  • TABLE 32 Italy IVF Market, by End Use, 2016 - 2027 (USD Million)
  • TABLE 33 Spain IVF Market, by Instrument, 2016 - 2027 (USD Million)
  • TABLE 34 Spain IVF Market, by procedure type, 2016 - 2027 (USD Million)
  • TABLE 35 Spain IVF Market, by End Use, 2016 - 2027 (USD Million)
  • TABLE 36 Netherlands IVF Market, by Instrument, 2016 - 2027 (USD Million)
  • TABLE 37 Netherlands IVF Market, by procedure type, 2016 - 2027 (USD Million)
  • TABLE 38 Netherlands IVF Market, by End Use, 2016 - 2027 (USD Million)
  • TABLE 39 Switzerland IVF Market, by Instrument, 2016 - 2027 (USD Million)
  • TABLE 40 Switzerland IVF Market, by procedure type, 2016 - 2027 (USD Million)
  • TABLE 41 Switzerland IVF Market, by End Use, 2016 - 2027 (USD Million)
  • TABLE 42 Belgium IVF Market, by Instrument, 2016 - 2027 (USD Million)
  • TABLE 43 Belgium IVF Market, by procedure type, 2016 - 2027 (USD Million)
  • TABLE 44 Belgium IVF Market, by End Use, 2016 - 2027 (USD Million)
  • TABLE 45 Asia Pacific IVF Market, by Country, 2016 - 2027 (USD Million)
  • TABLE 46 Asia Pacific IVF Market, by Instrument, 2016 - 2027 (USD Million)
  • TABLE 47 Asia Pacific IVF Market, by procedure type, 2016 - 2027 (USD Million)
  • TABLE 48 Asia Pacific IVF Market, by End Use, 2016 - 2027 (USD Million)
  • TABLE 49 Japan IVF Market, by Instrument, 2016 - 2027 (USD Million)
  • TABLE 50 Japan IVF Market, by procedure type, 2016 - 2027 (USD Million)
  • TABLE 51 Japan IVF Market, by End Use, 2016 - 2027 (USD Million)
  • TABLE 52 China IVF Market, by Instrument, 2016 - 2027 (USD Million)
  • TABLE 53 China IVF Market, by procedure type, 2016 - 2027 (USD Million)
  • TABLE 54 China IVF Market, by End Use, 2016 - 2027 (USD Million)
  • TABLE 55 India IVF Market, by Instrument, 2016 - 2027 (USD Million)
  • TABLE 56 India IVF Market, by procedure type, 2016 - 2027 (USD Million)
  • TABLE 57 India IVF Market, by End Use, 2016 - 2027 (USD Million)
  • TABLE 58 Latin America IVF Market, by Country, 2016 - 2027 (USD Million)
  • TABLE 59 Latin America IVF Market, by Instrument, 2016 - 2027 (USD Million)
  • TABLE 60 Latin America IVF Market, by procedure Type, 2016 - 2027 (USD Million)
  • TABLE 61 Latin America IVF Market, by End Use, 2016 - 2027 (USD Million)
  • TABLE 62 Brazil IVF Market, by Instrument, 2016 - 2027 (USD Million)
  • TABLE 63 Brazil IVF Market, by procedure Type, 2016 - 2027 (USD Million)
  • TABLE 64 Brazil IVF Market, by End Use, 2016 - 2027 (USD Million)
  • TABLE 65 Mexico IVF Market, by Instrument, 2016 - 2027 (USD Million)
  • TABLE 66 Mexico IVF Market, by procedure Type, 2016 - 2027 (USD Million)
  • TABLE 67 Mexico IVF Market, by End Use, 2016 - 2027 (USD Million)
  • TABLE 68 Middle East & Africa IVF Market, by Country, 2016 - 2027 (USD Million)
  • TABLE 69 Middle East & Africa IVF Market, by Instrument, 2016 - 2027 (USD Million)
  • TABLE 70 Middle East & Africa IVF Market, by procedure Type, 2016 - 2027 (USD Million)
  • TABLE 71 Middle East & Africa IVF Market, by End Use, 2016 - 2027 (USD Million)
  • TABLE 72 South Africa IVF Market, by Instrument, 2016 - 2027 (USD Million)
  • TABLE 73 South Africa IVF Market, by procedure Type, 2016 - 2027 (USD Million)
  • TABLE 74 South Africa IVF Market, by End Use, 2016 - 2027 (USD Million)

List of Figures

  • FIG. 1 Market research process
  • FIG. 2 Information procurement
  • FIG. 3 Primary research pattern
  • FIG. 4 Market research approaches
  • FIG. 5 Value Chain Based Sizing & Forecasting
  • FIG. 6 QFD modelling for market share assessment
  • FIG. 7 Market summary, 2018
  • FIG. 8 IVF: market segmentation
  • FIG. 9 IVF market revenue, (USD Million), 2016 - 2027
  • FIG. 10 IVF: Market dynamics
  • FIG. 11 Female age-based chance of conception
  • FIG. 12 Key opportunities prioritized
  • FIG. 13 IVF Porter's analysis
  • FIG. 14 IVF PESTEL analysis
  • FIG. 15 Global IVF market share, by instrument, 2019 & 2027
  • FIG. 16 Capital equipment market, 2016 - 2027 (USD Million)
  • FIG. 17 Culture media market, 2016 - 2027 (USD Million)
  • FIG. 18 IVF disposable devices market, 2016 - 2027 (USD Million)
  • FIG. 19 Global IVF market share, by type, 2019 & 2027
  • FIG. 20 Fresh nondonor market, 2016 - 2027 (USD Million)
  • FIG. 21 Frozen nondonor market, 2016 - 2027 (USD Million)
  • FIG. 22 Fresh donor market, 2016 - 2027 (USD Million)
  • FIG. 23 Frozen donor market, 2016 - 2027 (USD Million)
  • FIG. 24 Global IVF market share, by end use, 2019 & 2027
  • FIG. 25 Fertility clinics market, 2016 - 2027 (USD Million)
  • FIG. 26 Hospitals & other settings market, 2016 - 2027 (USD Million)
  • FIG. 27 Regional market place: Key takeaways
  • FIG. 28 Regional outlook, 2019 & 2027
  • FIG. 29 North America IVF service market, 2016 - 2027 (USD Million)
  • FIG. 30 North America IVF instrument market, 2016 - 2027 (USD Million)
  • FIG. 31 U.S. IVF service market, 2016 - 2027 (USD Million)
  • FIG. 32 U.S. IVF instrument market, 2016 - 2027 (USD Million)
  • FIG. 33 Canada IVF service market, 2016 - 2027 (USD Million)
  • FIG. 34 Canada IVF instrument market, 2016 - 2027 (USD Million)
  • FIG. 35 Europe IVF service market, 2016 - 2027 (USD Million)
  • FIG. 36 Europe IVF instrument market, 2016 - 2027 (USD Million)
  • FIG. 37 U.K. IVF service market, 2016 - 2027 (USD Million)
  • FIG. 38 U.K. IVF instrument market, 2016 - 2027 (USD Million)
  • FIG. 39 France IVF service market, 2016 - 2027 (USD Million)
  • FIG. 40 France IVF instrument market, 2016 - 2027 (USD Million)
  • FIG. 41 Germany IVF service market, 2016 - 2027 (USD Million)
  • FIG. 42 Germany IVF instrument market, 2016 - 2027 (USD Million)
  • FIG. 43 Italy IVF service market, 2016 - 2027 (USD Million)
  • FIG. 44 Italy IVF instrument market, 2016 - 2027 (USD Million)
  • FIG. 45 Spain IVF service market, 2016 - 2027 (USD Million)
  • FIG. 46 Spain IVF instrument market, 2016 - 2027 (USD Million)
  • FIG. 47 Netherlands IVF service market, 2016 - 2027 (USD Million)
  • FIG. 48 Netherlands IVF instrument market, 2016 - 2027 (USD Million)
  • FIG. 49 Switzerland IVF service market, 2016 - 2027 (USD Million)
  • FIG. 50 Switzerland IVF instrument market, 2016 - 2027 (USD Million)
  • FIG. 51 Belgium IVF service market, 2016 - 2027 (USD Million)
  • FIG. 52 Belgium IVF instrument market, 2016 - 2027 (USD Million)
  • FIG. 53 Asia Pacific IVF service market, 2016 - 2027 (USD Million)
  • FIG. 54 Asia Pacific IVF instrument market, 2016 - 2027 (USD Million)
  • FIG. 55 China IVF service market, 2016 - 2027 (USD Million)
  • FIG. 56 China IVF instrument market, 2016 - 2027 (USD Million)
  • FIG. 57 Japan IVF service market, 2016 - 2027 (USD Million)
  • FIG. 58 Japan IVF instrument market, 2016 - 2027 (USD Million)
  • FIG. 59 India IVF service market, 2016 - 2027 (USD Million)
  • FIG. 60 India IVF instrument market, 2016 - 2027 (USD Million)
  • FIG. 61 Latin America IVF service market, 2016 - 2027 (USD Million)
  • FIG. 62 Latin America IVF instrument market, 2016 - 2027 (USD Million)
  • FIG. 63 Brazil IVF service market, 2016 - 2027 (USD Million)
  • FIG. 64 Brazil IVF instrument market, 2016 - 2027 (USD Million)
  • FIG. 65 Mexico IVF service market, 2016 - 2027 (USD Million)
  • FIG. 66 Mexico IVF instrument market, 2016 - 2027 (USD Million)
  • FIG. 67 MEA IVF service market, 2016 - 2027 (USD Million)
  • FIG. 68 MEA IVF instrument market, 2016 - 2027 (USD Million)
  • FIG. 69 South Africa IVF service market, 2016 - 2027 (USD Million)
  • FIG. 70 South Africa IVF instrument market, 2016 - 2027 (USD Million)